Page last updated: 2024-08-24

topotecan and Lymphoma, T-Cell

topotecan has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Guan, M; Jia, N; Shao, Y; Wang, Y	1

Trials

1 trial(s) available for topotecan and Lymphoma, T-Cell

Article	Year
Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell; Male; Middle Aged; Topotecan; Treatment Outcome; Young Adult	2015

Article

Year

Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.

Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell; Male; Middle Aged; Topotecan; Treatment Outcome; Young Adult

2015